retatrutide for research purposes only 40mg | Premium 99%+ Purity Retatrutide (GLP-RT) Research Peptide for

For instance, rapid weight loss and reduced A1C could cause other side effects

the rest read out across 2026

AOD-9604 has been shown to efficiently burn fat without causing the body to crave unhealthy foods

Patients lost an average of 28.2lbs on a 1 mg dose, 24.9 on a 0.5 mg dose and 14.7lbs on a 0.25 mg dose compared with a 4.8lbs loss in the placebo group

Non-Alcoholic Fatty Liver Disease (NAFLD): Preliminary data suggest significant reductions in liver fat content (up to 90% of participants achieving normal liver fat levels), offering potential for studying NAFLD and non-alcoholic steatohepatitis (NASH)

Whilst it avoids the upper gastrointestinal effects of Saxenda, orlistat commonly causes oily stools, faecal urgency, and flatulence with discharge, particularly when dietary fat intake is high